Indivior Pharmaceuticals IncINDV
Price$35.38Intrinsic value$60.4271% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $60.42median of 4 methods · middle span $20-$101based on filings through 30 Jun 2026
Market Price $35.38Price as of 1 Oct 2026
Margin of Safety +70.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 40.9% (near-term consensus, capped) · years 2–5: 20.9%/yr (balance of the path).24.6% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 620.7%Yr 720.5%Yr 820.3%Yr 920.2%Yr 1020.0%
20.9% → 20.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1118.3%Yr 1216.6%Yr 1314.9%Yr 1413.2%Yr 1511.5%Yr 169.8%Yr 178.1%Yr 186.4%Yr 194.7%Yr 203.0%
20.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 9.8%
Volatility vs market (adjusted beta)1.09

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetIndivior Pharmaceuticals IncINDVHealth Care
Valuation
P/E12.7×
P/S3.2×
P/B—
EV / Revenue3.4×
EV / EBITDA—
Profitability
Gross margin80.0%
Operating margin20.9%
Net margin26.8%
FCF margin-8.3%
Returns
ROE—
ROA28.9%
ROIC624.6%
Growth
Revenue growth (YoY)12.0%
5-yr fwd EPS growth24.6%
Financial strength
Debt / Equity—
Current ratio0.84×
Altman Z-Score3.5
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.